Medicamen Biotech (BOM:531146) 3-Year EBITDA Growth Rate : 5.90% (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Medicamen Biotech 3-Year EBITDA Growth Rate?

Medicamen Biotech's EBITDA per Share for the three months ended in Dec. 2024 was ₹5.39.

During the past 12 months, Medicamen Biotech's average EBITDA Per Share Growth Rate was -9.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 5.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 3.70% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 15.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Medicamen Biotech was 45.30% per year. The lowest was -17.00% per year. And the median was 11.45% per year.

Competitive Comparison of Medicamen Biotech's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Medicamen Biotech's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medicamen Biotech's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicamen Biotech's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Medicamen Biotech's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Medicamen Biotech 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Medicamen Biotech (BOM:531146) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Medicamen Biotech 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Medicamen Biotech's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicamen Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicamen Biotech Ltd (BOM:531146) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

MEDICAMEQ:India

Address

1506, Chiranjiv Tower, 43, Nehru Place, New Delhi, IND, 110019

Website

https://www.medicamen.com

Medicamen Biotech Ltd is an Indian based pharmaceutical company. The company is engaged in developing and manufacturing Pharmaceuticals formulations products. It manufactures Tablets, Capsules, Oral liquids, Dry syrups, Ointments, and Oral rehydration solution. The company generates revenue from the sale of pharmaceutical products.

Medicamen Biotech Headlines

No Headlines